id | C00024000 |
---|---|
Name | Mycoin / Patulin / Clavitin / Tercinin / Leucopin / Clavicin / Expansion / Penicidin / Claviformin / 4-Hydroxy-4H-furo[3,2-c]pyran-2(6H)-one |
CAS RN | 149-29-1 |
Standard InChI | InChI=1S/C7H6O4/c8-6-3-4-5(11-6)1-2-10-7(4)9/h1,3,7,9H,2H2 |
Standard InChI (Main Layer) | InChI=1S/C7H6O4/c8-6-3-4-5(11-6)1-2-10-7(4)9/h1,3,7,9H,2H2 |
Phytochemical cluster | |
---|---|
KCF-S cluster | No. 7818 |
By standard InChI | CHEMBL294018 |
---|---|
By standard InChI Main Layer | CHEMBL294018 |
By LinkDB | C16748 |
---|
By CAS RN | D010365 |
---|
class name | count |
---|
family name | count |
---|---|
Aspergillaceae | 18 |
Thermoascaceae | 1 |
Gymnoascaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL294018 |
CHEMBL1226577
(1)
CHEMBL1613992
(1)
CHEMBL1613995 (1) |
7 / 44 |
Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL294018 |
CHEMBL1613842
(1)
|
4 / 2 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | CHEMBL294018 |
CHEMBL1794524
(1)
|
0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL294018 |
CHEMBL1794399
(1)
|
3 / 1 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | CHEMBL294018 |
CHEMBL1794371
(1)
CHEMBL1794471
(1)
|
0 / 0 |
P06493 | Cyclin-dependent kinase 1 | Cdc2 | CHEMBL294018 |
CHEMBL1226575
(1)
CHEMBL1226576
(1)
|
0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL294018 |
CHEMBL1794311
(1)
CHEMBL1794376
(1)
|
2 / 3 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL294018 |
CHEMBL1614458
(1)
|
0 / 0 |
P23528 | Cofilin-1 | Unclassified protein | CHEMBL294018 |
CHEMBL1226579
(1)
|
0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | CHEMBL294018 |
CHEMBL1963893
(1)
|
0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL294018 |
CHEMBL1794467
(1)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL294018 |
CHEMBL1794382
(1)
CHEMBL1794456
(1)
|
0 / 1 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | CHEMBL294018 |
CHEMBL1794510
(1)
|
5 / 3 |
Q96RI1 | Bile acid receptor | NR1H4 | CHEMBL294018 |
CHEMBL1794437
(1)
|
0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL294018 |
CHEMBL1614521
(1)
CHEMBL1613808
(1)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL294018 |
CHEMBL1794542
(1)
|
1 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL294018 |
CHEMBL1614211
(1)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL294018 |
CHEMBL1614250
(1)
CHEMBL1614421
(1)
|
4 / 3 |
P05412 | Transcription factor AP-1 | Transcription Factor | CHEMBL294018 |
CHEMBL1226578
(1)
|
0 / 0 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | CHEMBL294018 |
CHEMBL2114849
(1)
|
0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL294018 |
CHEMBL1794536
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D010365 | 467 |
ATF3
|
activating transcription factor 3 | Patulin results in increased expression of ATF3 mRNA |
increases expression
|
mRNA |
21844328
|
D010365 | 10018 |
BCL2L11
BAM BIM BOD |
BCL2-like 11 (apoptosis facilitator) | Patulin results in increased expression of BCL2L11 mRNA |
increases expression
|
mRNA |
21844328
|
D010365 | 637 |
BID
FP497 |
BH3 interacting domain death agonist | Patulin results in increased expression of BID mRNA |
increases expression
|
mRNA |
21844328
|
D010365 | 847 |
CAT
|
catalase (EC:1.11.1.6) | CAT protein results in decreased susceptibility to Patulin |
decreases response to substance
|
protein |
17090621
|
D010365 | 9076 |
CLDN1
CLD1 ILVASC SEMP1 |
claudin 1 | Patulin affects the localization of CLDN1 protein |
affects localization
|
protein |
19013514
|
D010365 | 1365 |
CLDN3
C7orf1 CPE-R2 CPETR2 HRVP1 RVP1 |
claudin 3 | Patulin affects the localization of CLDN3 protein |
affects localization
|
protein |
19013514
|
D010365 | 1364 |
CLDN4
CPE-R CPER CPETR CPETR1 WBSCR8 hCPE-R |
claudin 4 | Patulin affects the localization of CLDN4 protein |
affects localization
|
protein |
19013514
|
D010365 | 1649 |
DDIT3
CEBPZ CHOP CHOP-10 CHOP10 GADD153 |
DNA-damage-inducible transcript 3 | Patulin results in increased expression of DDIT3 mRNA |
increases expression
|
mRNA |
21844328
|
D010365 | 3458 |
IFNG
IFG IFI |
interferon, gamma | [Patulin results in decreased abundance of Glutathione] which results in decreased secretion of IFNG protein |
decreases abundance
/ decreases secretion |
protein |
18214930
|
D010365 | 3458 |
IFNG
IFG IFI |
interferon, gamma | Patulin results in decreased expression of IFNG mRNA |
decreases expression
|
mRNA |
12112629
|
D010365 | 3458 |
IFNG
IFG IFI |
interferon, gamma | Patulin results in decreased secretion of IFNG protein |
decreases secretion
|
protein |
12112629
|
D010365 | 3586 |
IL10
CSIF GVHDS IL-10 IL10A TGIF |
interleukin 10 | [Patulin results in decreased abundance of Glutathione] which results in decreased secretion of IL10 protein |
decreases abundance
/ decreases secretion |
protein |
18214930
|
D010365 | 3596 |
IL13
IL-13 P600 |
interleukin 13 | [Patulin results in decreased abundance of Glutathione] which results in decreased secretion of IL13 protein |
decreases abundance
/ decreases secretion |
protein |
18214930
|
D010365 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Patulin inhibits the reaction [IL1B protein results in increased expression of IL8 protein] |
decreases reaction
/ increases expression |
protein |
18308354
|
D010365 | 3565 |
IL4
BCGF-1 BCGF1 BSF-1 BSF1 IL-4 |
interleukin 4 | Patulin affects the secretion of IL4 protein |
affects secretion
|
protein |
12112629
|
D010365 | 3565 |
IL4
BCGF-1 BCGF1 BSF-1 BSF1 IL-4 |
interleukin 4 | [Patulin results in decreased abundance of Glutathione] which results in decreased secretion of IL4 protein |
decreases abundance
/ decreases secretion |
protein |
18214930
|
D010365 | 3565 |
IL4
BCGF-1 BCGF1 BSF-1 BSF1 IL-4 |
interleukin 4 | Patulin results in increased expression of IL4 mRNA |
increases expression
|
mRNA |
12112629
|
D010365 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Patulin inhibits the reaction [IL1B protein results in increased expression of IL8 protein] |
decreases reaction
/ increases expression |
protein |
18308354
|
D010365 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Patulin results in increased phosphorylation of MAPK1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
17090621
|
D010365 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | Patulin results in increased phosphorylation of MAPK1 protein |
increases phosphorylation
|
protein |
17090621
|
D010365 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Patulin results in increased phosphorylation of MAPK3 protein] |
decreases reaction
/ increases phosphorylation |
protein |
17090621
|
D010365 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | Patulin results in increased phosphorylation of MAPK3 protein |
increases phosphorylation
|
protein |
17090621
|
D010365 | 100506658 |
OCLN
BLCPMG |
occludin (EC:2.1.1.67) | 1,10-phenanthroline inhibits the reaction [Patulin results in increased degradation of OCLN protein] |
decreases reaction
/ increases degradation |
protein |
19013514
|
D010365 | 100506658 |
OCLN
BLCPMG |
occludin (EC:2.1.1.67) | Patulin results in increased degradation of OCLN protein |
increases degradation
|
protein |
19013514
|
D010365 | 100506658 |
OCLN
BLCPMG |
occludin (EC:2.1.1.67) | Zinc Sulfate inhibits the reaction [Patulin results in increased degradation of OCLN protein] |
decreases reaction
/ increases degradation |
protein |
19013514
|
D010365 | 5366 |
PMAIP1
APR NOXA |
phorbol-12-myristate-13-acetate-induced protein 1 | Patulin results in increased expression of PMAIP1 mRNA |
increases expression
|
mRNA |
21844328
|
D010365 | 23645 |
PPP1R15A
GADD34 |
protein phosphatase 1, regulatory subunit 15A | Patulin results in increased expression of PPP1R15A mRNA |
increases expression
|
mRNA |
21844328
|
D010365 | 6647 |
SOD1
ALS ALS1 IPOA SOD hSod1 homodimer |
superoxide dismutase 1, soluble (EC:1.15.1.1) | SOD1 protein results in decreased susceptibility to Patulin |
decreases response to substance
|
protein |
17090621
|
D010365 | 7082 |
TJP1
ZO-1 |
tight junction protein 1 | Patulin results in decreased expression of TJP1 protein |
decreases expression
|
protein |
19013514
|
D010365 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | Patulin results in increased expression of TP53 protein |
increases expression
|
protein |
19744505
|
D010365 | 7494 |
XBP1
TREB5 XBP-1 XBP2 |
X-box binding protein 1 | Patulin results in increased splicing of XBP1 mRNA |
increases splicing
|
mRNA |
21844328
|
OMIM | preferred title | UniProt |
---|---|---|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
%606641 | Body mass index; bmi |
P37231
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#211980 | Lung cancer |
P04637
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#601665 | Obesity |
P37231
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG | disease name | UniProt |
---|---|---|
H00026 | Endometrial Cancer |
P03372
(marker)
P04637 (related) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
|
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P37231
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |